Cerence Inc. (CRNC) EVP Jennifer Salinas sells 25,998 shares in August trade

Rhea-AI Filing Summary

Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, reported a sale of 25,998 shares of common stock on 2026-08-10 in an open-market or private transaction. The shares were sold at a weighted average price of $8.8279 per share, with trade prices ranging from $8.675 to $8.965. Following this transaction, she directly holds 694,029 shares of Cerence common stock.

Insider Trade Summary

Net Seller: 25,998 shares

Net Sell 1 txn

Insider Salinas Jennifer

Role EVP Chief Admin Officer

Sold 25,998 shs ($230K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	25,998	$8.8279	$230K

Holdings After Transaction: Common Stock — 694,029 shares (Direct)

Footnotes (2)

1. F1. The sale reported on this Form 4 represents shares sold by the Reporting Person.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.675 to $8.965, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Key Figures

Shares sold: 25,998 shares Weighted average sale price: $8.8279 per share Price range: $8.675 to $8.965 per share +1 more

4 metrics

Shares sold 25,998 shares Common stock transaction on 2026-08-10

Weighted average sale price $8.8279 per share Sale of 25,998 shares of common stock

Price range $8.675 to $8.965 per share Multiple transactions within this range on 2026-08-10

Shares owned after transaction 694,029 shares Direct holdings of common stock following the sale

Key Terms

weighted average price, open market or private transaction, Form 4

3 terms

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

Form 4 regulatory

"The sale reported on this Form 4 represents shares sold"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 05:49 PM Accepted by SEC EDGAR 08/12/2026 - 05:48 PM Learn about SEC filing dates

FAQ

What did Cerence Inc. (CRNC) executive Jennifer Salinas report on this Form 4?

Jennifer Salinas reported a sale of 25,998 Cerence Inc. common shares on 2026-08-10. The transaction was reported as a sale in an open market or private transaction and left her with 694,029 shares directly owned.

At what price did Jennifer Salinas sell Cerence (CRNC) shares?

The reported sale used a weighted average price of $8.8279 per share. According to the disclosure, the individual trades occurred at prices ranging from $8.675 to $8.965 per share, inclusive, across multiple transactions.

How many Cerence (CRNC) shares does Jennifer Salinas own after this transaction?

After the reported sale, Jennifer Salinas directly owns 694,029 shares of Cerence common stock. This figure reflects her post-transaction holdings as disclosed in the Form 4 filing for the 2026-08-10 transaction.

How many Cerence Inc. (CRNC) shares did Jennifer Salinas sell?

Jennifer Salinas sold 25,998 shares of Cerence common stock. The transaction is characterized as a sale in an open market or private transaction and is the only transaction reported in this Form 4 filing.

Was Jennifer Salinas’s Cerence (CRNC) stock sale under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked, and no footnote describes a trading plan. The sale is therefore not identified in the disclosure as being executed under a Rule 10b5-1 plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salinas Jennifer

(Last) (First) (Middle)

1500 DISTRICT AVE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Chief Admin Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		S		25,998(1)	D	$8.8279(2)	694,029	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 represents shares sold by the Reporting Person.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.675 to $8.965, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Jennifer Salinas Attorney-in-Fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)